Back

Multidisciplinary, imaging-guided Potts shunt in pulmonary hypertension: timing and risk assessment

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Risk assessment in pulmonary arterial hypertension Pulmonary Hypertension ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Zhuoyuan Xu

Shanghai Childrens Medical Center, Shanghai (China)

6 More presentations in this session

Presentation thumbnail
A modified 4-strata risk assessment incorporating TAPSE/sPAP for pulmonary arterial hypertension: evidence from a large chinese real-world cohort
Doctor S. Li (Beijing, CN)
Abstract
Presentation thumbnail
Discordance between PAH risk scores in systemic sclerosis–associated pulmonary arterial hypertension
Doctor A. Cruz Utrilla (Madrid, ES)
Abstract
Presentation thumbnail
Impact of cardiovascular comorbidity burden in pulmonary arterial hypertension: a propensity score-matched analysis
Doctor Q. Wang (Beijing, CN)
Abstract
Presentation thumbnail
Patient-reported physical activity improves risk stratification beyond COMPERA 2.0 in PAH and CTEPH
Mrs I. Silfversparre (Gothenburg, SE)
Abstract
Presentation thumbnail
Age as an independent predictor of mortality in idiopathic and connective tissue disease-associated PAH: from the Spanish Registry of Pulmonary Hypertension (REHAP Registry)
Doctor A. Cruz Utrilla (Madrid, ES)
Abstract

Access the full session

Session thumbnail
Risk assessment in pulmonary arterial hypertension

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
ESC Journals
Anatomy vs. shunt fraction: haemodynamic consequences in atrial septal defects and partial anomalous pulmonary venous connection—a comprehensive CMR study
6 January 2025
thumbnail
Congress Presentation
Real-life evidence of the use of subcutaneous treprostinil in pulmonary hypertension in Argentina
1 July 2021
thumbnail
Webinar
Multimodality imaging for the assessment of patients with pulmonary arterial hypertension
23 September 2021
thumbnail
Congress Presentation
Predictive factors of outcome in patients with Tetralogy of Fallot (TOF) after pulmonary valve replacement: preliminary data of our Centre experience (2010-2020)
9 December 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources